Clinical Pathology

Review | The promise of precision medicine in rheumatology.

12 Jul, 2022 | 12:38h | UTC

The promise of precision medicine in rheumatology – Nature Reviews Rheumatology

 

Commentary on Twitter

A Review in @NatureMedicine discusses recent efforts to dissect cellular and molecular heterogeneity across multiple systemic autoimmune rheumatic diseases and future directions for implementing stratification approaches for SARD treatment. https://t.co/5EGTkQjasR pic.twitter.com/NAgbnyU96O

— Nature Portfolio (@NaturePortfolio) July 8, 2022

 

---

Guideline Synopsis | Evaluation and diagnosis of chest pain.

4 Jul, 2022 | 12:49h | UTC

Evaluation and Diagnosis of Chest Pain – JAMA (free for a limited period)

Original Guideline:

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – Journal of the American College of Cardiology

News Release: First-Ever Guideline Focused Solely on Chest Pain Evaluation, Diagnosis Released

Guideline Hub: Guideline for the Evaluation and Diagnosis of Chest Pain

Key Points: 2021 AHA/ACC Chest Pain Guideline – American College of Cardiology

Commentary: New Chest Pain Guidelines Out at Last: Most Tests Have a Role – TCTMD

---

Editorial | Circulating tumor cell burden as a component of staging in multiple myeloma: ready for prime time?

4 Jul, 2022 | 11:48h | UTC

Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time? – Journal of Clinical Oncology

Original Studies:

Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma – Journal of Clinical Oncology

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma – Journal of Clinical Oncology

Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile – Journal of Clinical Oncology

---

Cohort Study: B‐Type Natriuretic Peptide and long‐term cardiovascular mortality in patients with coronary heart disease.

1 Jul, 2022 | 11:04h | UTC

B‐Type Natriuretic Peptide and Long‐Term Cardiovascular Mortality in Patients With Coronary Heart Disease – Journal of the American Heart Association

 

---

ASCO Guideline Update: Biomarkers for systemic therapy in metastatic breast cancer.

29 Jun, 2022 | 11:40h | UTC

Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update – Journal of Clinical Oncology

 

Commentary on Twitter

‼️ 🆕 @ASCO guideline update published in #JCO by @lynnhenrymd et al: Biomarkers for #SystemicTherapy in Metastatic #BreastCancer ➡️ https://t.co/qAzT9WNKTF #bcsm #biomarkers @AngieDemichele pic.twitter.com/3WtAt8TK5w

— Journal of Clinical Oncology (@JCO_ASCO) June 27, 2022

 

---

Cohort Study: Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes.

20 Jun, 2022 | 10:36h | UTC

Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank – eClinicalMedicine

 

Commentary on Twitter

Still remember working on this in 2019 but it's out today!

Gamma-GT level has a strong association with mortality outcomes and could add to the prediction of CV mortality
https://t.co/0lzqGfgiGc pic.twitter.com/C8tSZLWlI2

— Fred Ho (@fredho42) May 13, 2022

Under a CC BY-NC-ND 4.0 license

 

---